Sagent
Pharmaceuticals focuses on the development and commercialization of injectable pharmaceutical products for cancer, oncology and urology... Read moreSagent
Pharmaceuticals focuses on the development and commercialization of injectable pharmaceutical products for cancer, oncology and urology... Read more
CEO
Peter Kaemmerer
News
Mar 26, 2025
The Economic Times
Sagent: Kedaara, TA Associates vie for minority stake in Sagent Pharma
May 30, 2024
Nasdaq
Sagent: Sagent Pharma Recalls Chemotherapy Drug Docetaxel Injection
Jun 14, 2023
The Business Journals
Sagent: Pharma company cuts 81 jobs at Raleigh facility
Nov 23, 2021
RTTNews
Sagent Pharmaceuticals: Sagent Pharma Recalls Seizure Drug Levetiracetam Injection
Nov 19, 2021
Markets Insider
Sagent Pharmaceuticals: Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Levetiracetam Injection, USP Due to Lack of Sterility Assurance
Mar 15, 2021
Outsourcing-Pharma
Sagent Pharmaceuticals: Sagent issues voluntary recall of phenylephrine hydrochloride vials
Mar 11, 2021
Markets Insider
Sagent Pharmaceuticals: Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Phenylephrine Hydrochloride Injection, USP, 10 mg/mL Due to Potential Lack of Sterility Assurance
Feb 12, 2021
StreetInsider
Press Release: Sagent Pharmaceuticals : Sagent Pharmaceuticals Announces Start of NIAID-Sponsored Study Investigating COVID-19 Treatments in Outpatients
Nov 12, 2020
PharmaLeaders
Sagent Pharmaceuticals: Sagent Pharmaceuticals launches phase 2 trial to evaluate Camostat Mesilate for Covid-19 treatment
Sep 05, 2019
PR Newswire
Press Release: Sagent Pharmaceuticals : Sagent Pharmaceuticals Announces FDA Acceptance of Omega Manufacturing Site
Sagent Competitors
1
2
3
4
5
6
7
8
9